• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Coumaric acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Hydroxycinnamic acids and derivatives Coumaric acids and derivatives

Introduction to trans-3-Ethoxycinnamic Acid (CAS No. 103986-73-8)

trans-3-Ethoxycinnamic acid is a significant compound in the field of pharmaceutical chemistry and biochemistry, renowned for its versatile applications and potential therapeutic benefits. With the CAS number 103986-73-8, this compound has garnered attention due to its unique chemical structure and biological activities. This introduction aims to provide a comprehensive overview of trans-3-Ethoxycinnamic acid, delving into its chemical properties, synthesis methods, and the latest research findings that highlight its importance in modern medicine.

The molecular structure of trans-3-Ethoxycinnamic acid consists of a cinnamic acid derivative with an ethoxy group attached to the third carbon atom of the phenyl ring. This substitution enhances its solubility and bioavailability, making it an attractive candidate for drug development. The compound exhibits remarkable stability under various conditions, which is crucial for pharmaceutical applications where shelf life and purity are paramount.

In recent years, trans-3-Ethoxycinnamic acid has been extensively studied for its potential role in anti-inflammatory and antioxidant therapies. Research has demonstrated that this compound can modulate various biological pathways, including those involved in immune response and oxidative stress. For instance, studies have shown that trans-3-Ethoxycinnamic acid can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, thereby reducing inflammation in affected tissues.

The synthesis of trans-3-Ethoxycinnamic acid typically involves the ethylation of 3-hydroxycinnamic acid using appropriate alkylating agents under controlled conditions. Advanced synthetic techniques, such as catalytic hydrogenation and enzymatic reactions, have been employed to improve yield and purity. These methods ensure that the final product meets the stringent requirements of pharmaceutical-grade materials.

One of the most compelling aspects of trans-3-Ethoxycinnamic acid is its potential in drug delivery systems. Researchers have explored its use as a carrier molecule for poorly soluble drugs, enhancing their bioavailability and therapeutic efficacy. The ethoxy group in its structure allows for interactions with biological membranes, facilitating the transport of active ingredients across cellular barriers.

The pharmacological properties of trans-3-Ethoxycinnamic acid have also been investigated in the context of neurodegenerative diseases. Preliminary studies suggest that it may help protect against neuronal damage by scavenging free radicals and preventing oxidative stress-induced cell death. This makes it a promising candidate for developing treatments for conditions such as Alzheimer's and Parkinson's disease.

In addition to its therapeutic applications, trans-3-Ethoxycinnamic acid has shown promise in cosmetic formulations. Its antioxidant properties make it an effective ingredient in anti-aging creams and serums, helping to combat skin damage caused by environmental factors like UV radiation and pollution. The compound's ability to enhance collagen production further underscores its potential in maintaining skin health.

The latest research on trans-3-Ethoxycinnamic acid also highlights its role in cancer therapy. Studies have indicated that it can inhibit the growth of certain cancer cell lines by disrupting critical signaling pathways involved in tumor progression. This discovery opens up new avenues for developing targeted therapies that leverage the unique properties of this compound.

The safety profile of trans-3-Ethoxycinnamic acid has been thoroughly evaluated through preclinical studies, which have shown no significant toxicity at relevant doses. However, further clinical trials are necessary to confirm its efficacy and safety in human populations. These trials will provide valuable insights into optimal dosing regimens and potential side effects.

The industrial production of trans-3-Ethoxycinnamic acid has also seen advancements, with manufacturers adopting green chemistry principles to minimize environmental impact. Solvent-free reactions and biocatalytic processes have been implemented to reduce waste and energy consumption, aligning with global efforts to promote sustainable practices.

In conclusion, -is a multifaceted compound with significant potential in pharmaceuticals, cosmetics, and beyond. Its unique chemical properties and biological activities make it a valuable asset in modern medicine, with ongoing research uncovering new therapeutic applications. As our understanding of this compound continues to grow, so too will its role in enhancing human health and well-being.

• 2373-79-7(3-(4-ethoxyphenyl)prop-2-enoic acid)
• 6099-04-3(3-Methoxycinnamic acid)
• 16909-11-8(3,5-Dimethoxycinnamic acid)
• 15486-19-8(4-Acetoxycinnamic acid)
• 17570-26-2(3-(3-methoxyphenyl)prop-2-enoic acid)
• 122024-75-3((2E)-3-3-(Benzyloxy)phenylprop-2-enoic Acid)
• 830-09-1(3-(4-methoxyphenyl)prop-2-enoic acid)
• 943-89-5((E)-3-(4-Methoxyphenyl)acrylic acid)
• 77124-20-0(3-(3-Phenoxyphenyl)acrylic Acid)
• 69033-81-4(4-Propoxycinnamic Acid)